The US FTC reaches a record $1.2 billion proposed pay-for-delay settlement and injunctive relief restricting future similar settlements of patent infringement cases (Cephalon)

Federal Trade Commission Reaches Record $1.2 Billion Proposed “Pay for Delay” Settlement with Cephalon and Injunctive Relief Restricting Future Similar Settlements of Patent Infringement Cases* Last week, on the eve of trial, the Federal Trade Commission (“FTC”) reached a proposed settlement in its civil antitrust lawsuit against Cephalon, Inc. (“Cephalon”). The FTC challenged Cephalon’s prior settlement of patent infringement litigation brought against generic drug makers seeking to enter the market with a copy of Cephalon’s blockbuster sleep-disorder drug Provigil. The long-running antitrust case began in 2008 when the FTC sued Cephalon, arguing that there was no rational economic basis for Cephalon’s simultaneous settlement of its patent infringement case and entry into separate business

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • Weil, Gotshal & Manges (New York)
  • Weil, Gotshal & Manges (New York)

Citation

Eric S. Hochstadt, Albert F. Cahn, The US FTC reaches a record $1.2 billion proposed pay-for-delay settlement and injunctive relief restricting future similar settlements of patent infringement cases (Cephalon), 28 mai 2015, e-Competitions May 2015, Art. N° 73852

Visites 814

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues